Amid the ongoing expansion of the US FDA's accelerated approval program via the 21st Century Cures Act, safety events for drugs approved through the pathway have been prominent throughout the twenty-first century according to a study.
Postmarketing events were statistically significantly more frequent among novel drugs and biologics approved between 2001 and 2010 that garnered accelerated...




